肺功能与慢性肾脏病发病风险:ARIC研究
ARIC前瞻性队列研究纳入14,946名45-64岁参与者,随访至2012年,中位随访23.6年。研究发现,用力肺活量占预计值百分比(FVC%pred)最低四分位组与最高组相比,终末期肾病(ESRD)发生风险显著增加(HR 1.72,95%CI 1.31-2.26),混合型肺功能模式风险最高(HR 2.28,95%CI 1.50-3.45)。
要点
- FVC%pred最低四分位组ESRD风险是最高的1.72倍(95%CI 1.31-2.26)。
- 混合型肺功能模式者ESRD风险最高,HR为2.28(95%CI 1.50-3.45)。
- 肺功能减退与CKD进展独立相关,需监测肾功能。
核心结论
- 肺功能减退,尤其是FVC%pred降低,与CKD进展独立相关。
- 研究提示肺功能减退可能参与CKD发病的病理生理过程,需对肺功能减退者监测肾功能。
研究设计与样本
- 前瞻性队列研究,纳入ARIC研究中14,946名45-64岁基线(1987-1989年)参与者,随访至2012年。
- 男性占45.0%,黑人占25.2%。
主要发现
- 中位随访23.6年,526名(3.5%)参与者发生ESRD。
- 调整混杂因素后,FVC%pred最低 vs 最高四分位组ESRD的病因特异性HR为1.72(95%CI 1.31-2.26)。
- FEV1/FVC最低 vs 最高四分位组ESRD的病因特异性HR为1.33(95%CI 1.03-1.73)。
- 与高正常肺功能模式相比,混合型模式(FVC%pred<80%且FEV1/FVC<70%)ESRD风险最高,HR 2.28(95%CI 1.50-3.45)。
- 限制型模式(FVC%pred<80%且FEV1/FVC≥70%)HR 2.03(95%CI 1.47-2.81),阻塞型模式(FVC%pred≥80%且FEV1/FVC<70%)HR 1.47(95%CI 1.09-1.99),低正常型模式HR 1.21(95%CI 0.94-1.55)。
关键数值与推荐
- FVC%pred最低四分位组ESRD风险HR 1.72(95%CI 1.31-2.26)。
- 混合型肺功能模式ESRD风险HR 2.28(95%CI 1.50-3.45)。
临床怎么用
- 对肺功能减退者,尤其是FVC%pred降低者,应监测肾功能以早期发现CKD进展。
局限性
- 中重度肺功能障碍参与者数量有限。
- 肺功能检查仅在基线进行。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Reduced lung function is associated with clinical outcomes such as cardiovascular disease. However, little is known about its association with incident end-stage renal disease (ESRD) and chronic kidney disease (CKD). STUDY DESIGN: Prospective cohort study. SETTING & PARTICIPANTS: 14,946 participants aged 45 to 64 years at baseline (1987-1989) in the Atherosclerosis Risk in Communities (ARIC) Study (45.0% men and 25.2% black), with follow-up through 2012. PREDICTORS: Race- and sex-specific quartiles of percent-predicted forced vital capacity (FVC) and the proportion of forced expiratory volume in 1 second of expiration to FVC (FEV1/FVC) at baseline determined with spirometry. OUTCOMES: Incident ESRD (defined here as renal replacement therapy or death due to CKD) as the primary outcome and incident CKD (defined here as ESRD, ≥25% decline in estimated glomerular filtration rate to a level <60mL/min/1.73m2, or CKD-related hospitalizations/deaths) as the secondary outcome. RESULTS: During a median follow-up of 23.6 years, 526 (3.5%) participants developed ESRD. After adjusting for potential confounders, the cause-specific HR of incident ESRD for the lowest (vs highest) quartile was 1.72 (95% CI, 1.31-2.26) for percent-predicted FVC and 1.33 (95% CI, 1.03-1.73) for FEV1/FVC. Compared to a high-normal lung function pattern, a mixed pattern (ie, percent-predicted FVC<80% and FEV1/FVC<70%; 3.4% of participants) demonstrated the highest adjusted cause-specific HR of ESRD at 2.28 (95% CI, 1.50-3.45), followed by the restrictive pattern (ie, percent-predicted FVC<80% and FEV1/FVC≥70%; 4.8% of participants) at 2.03 (95% CI, 1.47-2.81), obstructive pattern (ie, percent-predicted FVC≥80% and FEV1/FVC<70%; 18.9% of participants) at 1.47 (95% CI, 1.09-1.99), and low-normal pattern (ie, percent-predicted FVC 80%-<100% and FEV1/FVC≥70%, or percent-predicted FVC≥80% and FEV1/FVC 70%-<75%; 44.3% of participants) at 1.21 (95% CI, 0.94-1.55). Similar associations were seen with incident CKD. LIMITATIONS: Limited number of participants with moderate/severe lung dysfunction and spirometry only at baseline. CONCLUSIONS: Reduced lung function, particularly lower percent-predicted FVC, is independently associated with CKD progression. Our findings suggest a potential pathophysiologic contribution of reduced lung function to the development of CKD and a need for monitoring kidney function in persons with reduced lung function.
引用
- Sumida K, Kwak L, Grams ME, et al. Lung Function and Incident Kidney Disease: The Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis. 2017. PMID: 28754455. doi:10.1053/j.ajkd.2017.05.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。